N/A
Completed N=53
physicAl aCtiviTy In minOrity womeN With Asthma Intervention
Source: ClinicalTrials.gov NCT03265665 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcomePrimary: Feasibility of Intervention-Recruitment — 53 participants
Summary
The ACTION intervention: physicAl aCtiviTy In minOrity womeN with asthma is a 3lifestyle physical activity intervention refined to be applicable for sedentary African American (AA) women with asthma. The main outcome of this study is to test the feasibility, acceptability and estimate the efficacy of the ACTION intervention in a randomized controlled pilot of 80 AA women with asthma within a pragmatic community setting at 24-weeks.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Intervention-Recruitment |
53 | — |
| PRIMARY Feasibility of Intervention-Withdrawals |
2; 2 | — |
| PRIMARY Feasibility of Lifestyle PA Intervention |
19; 21 | — |
| PRIMARY Acceptability of Lifestyle PA Intervention |
6.88 | — |
| PRIMARY Acceptability of Lifestyle PA Intervention-Qualitative Data |
— | — |
| SECONDARY Light Physical Activity Levels |
567.13; 278.66 | — |
| SECONDARY Asthma Quality of Life Questionnaire (AQLQ) |
5.24; 4.70 | — |
| SECONDARY Asthma Control Questionnaire (ACQ-6) |
1.28; 1.87 | — |
| SECONDARY Daily Step Counts |
4372.73; 5196.32 | — |
| SECONDARY Moderate Physical Activity Levels |
16.63; 18.07 | — |
| SECONDARY Vigorous Physical Activity Levels |
0.37; 1.14 | — |
Eligibility Criteria
Inclusion Criteria
- Self-identify as female and black or AA
- Age 18-70
- Sub-optimally controlled persistent asthma based on Asthma Control Test (ACT 20 pack years)
- Poorly controlled high blood pressure (BP >180/100 at baseline visit)
- Family/household member of another study participant or staff member
- Inability to speak, read or understand English;
- Investigator discretion for safety or protocol adherence reasons
- Participation in ACTION focus groups (Aim 1) or pre-pilot (Aim 2) of the study
Data sourced from ClinicalTrials.gov (NCT03265665). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.